1187 Non-24-hour Sleep-Wake Disorder in Transgender Male Receiving Exogenous Testosterone

Joseph Collins,Joseph Espiritu

DOI: https://doi.org/10.1093/sleep/zsae067.01187

IF: 6.313

2024-04-20

SLEEP

Abstract:Abstract Introduction Little is known about the effects of hormonal therapy for adolescents undergoing transgender care. We present a case of a biologic female being treated with exogenous testosterone for transgender care who develops non-24-hour circadian rhythm disorder (N24SWD), a rare sleep-wake disorder, most commonly seen in individuals who are totally blind. Report of case(s) A 19-year-old transgender man (female at birth) presented to our clinic with complaints of inconsistent sleep schedule and daytime sleepiness. They have a past medical history of anxiety, obsessive-compulsive disorder (OCD), and social phobia. As a younger teenager, the patient reported having a delayed sleep phase pattern. A year ago, the patient started exogenous testosterone injections every 2 weeks. Over the past year, the patient noticed a change in sleep pattern, described as going to bed and waking up 1-2 hours later, with each passing day. This was verified with 4 weeks of sleep diaries. The patient was diagnosed with N24SWD and was prescribed melatonin 0.5 mg 6 hours before bedtime without benefit. Other behavioral modifications with set wake times, bright light therapy, and morning exercises were not helpful. We prescribed tasimelteon, a melatonin receptor agonist, but it was denied by the health insurance. The current management plan is to optimize sleep behaviors and continue psychiatric follow-up for mood disorders while appealing the denial of tasimelteon. Conclusion Transgender individuals are particularly vulnerable to sleep disorders. Testosterone replacement therapy has been linked to sleep disordered breathing, insomnia, and sleep disruption. It has not been well established what role hormone therapy, and specifically testosterone in this case, plays on an individual’s circadian rhythm. Previous studies have demonstrated that melatonin production decreases more abruptly for women going through menopause and that delayed sleep phase in teenagers may be due to hormonal changes during puberty, although pathophysiology is not fully understood5. A similar case of a transgender male receiving exogenous testosterone was recently reported. More research is needed to elucidate the potential adverse effect of testosterone replacement on the circadian rhythm of the growing population of patients undergoing transgender care. Support (if any)

neurosciences,clinical neurology